Back to search
FDAFDA · Food and drugs·Recall number D-0259-2021

Meclizine HCl Tablets, USP, 25 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-133-01

Published February 24, 2021 · Recall initiated: February 4, 2021

Summary

FDA records drug Class II recall D-0259-2021, published February 24, 2021 and initiated February 4, 2021. Recalling firm: Wilshire Pharmaceuticals Inc; Status: Terminated; Reported quantity: 35928 bottles; Lot: Lot #: 18030329, 18030330, 18030331, Exp 03/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wilshire Pharmaceuticals Inc
Distributor
FL, TX
Lot
Lot #: 18030329, 18030330, 18030331, Exp 03/2021.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Meclizine HCl Tablets, USP, 25 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-133-01 recalled?

Yes. FDA published recall D-0259-2021 on February 24, 2021. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter